Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;42(7):1014-1021.
doi: 10.1097/MAO.0000000000003109.

Cochlear Implantation in NF2 Patients Without Intracochlear Schwannoma Removal

Susan T Eitutis  1 , Thijs Jansen  2 , Daniele Borsetto  2 , Daniel J Scoffings  3 , Yu Chuen Tam  1 , Tsvetemira Panova  1 , James R Tysome  2 , Neil P Donnelly  2 , Patrick R Axon  2 , Manohar L Bance  2   4
Affiliations

Cochlear Implantation in NF2 Patients Without Intracochlear Schwannoma Removal

Susan T Eitutis et al. Otol Neurotol. .

Abstract

Objective: To determine if cochlear implantation without removal of inner ear schwannomas (IES) is an effective treatment option for Neurofibromatosis 2 (NF2) patients. To determine how the presence of an intracochlear schwannoma might impact cochlear implant (CI) outcomes and programming parameters.

Study design: Retrospective chart review.

Setting: Tertiary center for cochlear and auditory brainstem implantation.

Patients: Of 10 NF2 patients with IES, 8 are reported with no previous tumor removal on the implanted ear.

Interventions: Cochlear implant without tumor removal.

Main outcome measures: Performance outcomes with CI at least 1-year post intervention. Programming parameters, including impedances, for patients with IES.

Results: All patients had full insertion of the electrode arrays with round window approaches. Performance outcomes ranged from 0 to 100% for Bamford-Kowal-Bench sentences. Impedance measurements for active electrodes for patients with IES were comparable to those measured in patients without vestibular schwannoma (VS). Only patients who had radiation treatment before receiving their implant had elevated threshold requirements for CI programming compared with CI recipients without VS.

Conclusion: Cochlear implantation without tumor removal is an effective option for treating NF2 patients with IES. The presence of an intracochlear tumor did not have an impact on CI performance or programming requirements compared with patients without VS; however, previous treatment with radiation may be related to elevated current requirements in the CI settings.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflicts of interest.

References

    1. Carlson ML, Neff BA, Sladen DP, Link MJ, Driscoll CL. Cochlear implantation in patients with intracochlear and intralabyrinthine schwannomas. Otol Neurotol . 2016;37:647–53.
    1. Choudhury B, Carlson ML, Jethanamest D. Intralabyrinthine schwannomas: Disease presentation, tumor management, and hearing rehabilitation. J Neurol Surgery B Skull Base 2019; 80:196–202.
    1. Bittencourt AG, Alves RD, Ikari LS, Burke PR, Gebrim EMS, Bento RF. Intracochlear schwannoma: Diagnosis and management. Int Arch Otorhinolaryngol 2014; 18:322–324.
    1. Borsetto D, Hammond-Kenny A, Tysome JR, et al. Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: A systematic review. Cochlear Implants Int 2020; 21:9–17.
    1. Lloyd SKW, King AT, Rutherford SA, et al. Hearing optimisation in neurofibromatosis type 2: A systematic review. Clin Otolaryngol 2017; 42:1329–1337.